RUCDR Infinite Biologics Receives $19M for NIDA Genetics Center | GenomeWeb

NEW YORK (GenomeWeb) – RUCDR Infinite Biologics, a unit of the Rutgers Human Genetics Institute of New Jersey, has received a $19 million contract from the National Institute on Drug Abuse to expand the service offerings it provides through the NIDA Center for Genetic Studies, the Rutgers Office of Research and Economic Development said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: parent-of-origin effects, framework to uncover clinically important mutations from whole genome sequence data, and more.

A survey of Cincinnati schoolchildren finds teenagers want to know their genetic predisposition to disease, LiveScience reports.

More and more universities are helping their researchers patent their inventions, the Los Angeles Times reports.

Cancer Research UK unveils seven 'grand challenges' that it will fund researchers to tackle.